Istinye University Faculty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Frontline cemiplimab plus chemotherapy improved overall survival and progression-free survival compared with investigator’s choice of chemotherapy for patients with PD-L1–positive non–small cell lung cancer that has metastasized to the brain.

United statesEuropean lung cancer congressIstinye university faculty of medicineIstinye university facultyLung cancerAmerican indianLung cancer congressFrontline cemiplimab plus chemotherapyPatients with pd l1 positive non small cell lung cancerEmpower lung 1 trialSaadettin kılıçkap